Europe Softens on GM Crops

A new agreement in the European Union allows genetically engineered crops to be approved without member-state votes, likely allowing several GMO foods to enter the market.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, TIM GREENThe European Union (EU) Parliament and representatives of the EU’s member states last week (December 3) reached a compromise regarding genetically engineered, or genetically modified (GM), crops. According to the new agreement, the EU does not need a majority of member states to agree with its decision to approve a GM food product for human consumption. Rather, the EU will make its decision independent of member states, each of which will then be able to overrule the approval in its own country.

As a result of this new compromise, several GM crops that “have been in limbo for years” are now likely to inch toward the market, Nature reported. Crops that stand to benefit from the new arrangement include a variety of corn called Bt11, which has been under EU regulatory review since the mid-1990s, for example. “It means that those who don’t want to ignore the science can go ahead and use the science more easily” despite widespread GM opposition in Europe, Jonathan Jones, a plant researcher at the Sainsbury Laboratory in Norwich, U.K., told the publication.

The new agreement must still be approved by the full EU Parliament and a separate committee of member-state representatives, and the legislation necessary to grant member states the right ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies